Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Diabetes is defined by its association with hyperglycemia-specific microvascular complications; however, it also imparts a two- to fourfold risk of cardiovascular disease (CVD). Although microvascular complications can lead to significant morbidity and premature mortality, by far the greatest cause of death in people with diabetes is CVD. Results from randomized controlled trials have demonstrated conclusively that the risk of microvascular complications can be reduced by intensive glycemic control in patients with type 1 (1,2) and type 2 diabetes (3–5). In the Diabetes Control and Complications Trial (DCCT), there was an ∼60% reduction in development or progression of diabetic retinopathy, nephropathy, and neuropathy between the intensively treated group (goal A1C <6.05%, mean achieved A1C ∼7%) and the standard group (A1C ∼9%) over an average of 6.5 years. The relationship between glucose control (as reflected by the mean on-study A1C value) and risk of complications was log-linear and extended down to the normal A1C range (<6%) with no threshold noted. In the UK Prospective Diabetes Study (UKPDS), participants newly diagnosed with type 2 diabetes were followed for 10 years, and intensive control (median A1C 7.0%) was found to reduce the overall microvascular complication rate by 25% compared with conventional treatment (median A1C 7.9%). Here, too, secondary analyses showed a continuous relationship between the risk of microvascular complications and glycemia extending into the normal range of A1C, with no glycemic threshold. On the basis of these two large controlled trials, along with smaller studies and numerous epidemiologic reports, the consistent findings related to microvascular risk reduction with intensive glycemic control have led the American Diabetes Association (ADA) to recommend an A1C goal of <7% for most adults with diabetes (6), recognizing that more or less stringent goals may be appropriate for certain patients. Whereas many epidemiologic studies and meta-analyses …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, severe hypoglycemia may also be a marker of vulnerability, without any direct causal contribution to the increased mortality (72).”
From Hypoglycemia (2018) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Research works printed but not linked: 1
- Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vikek ME, Henderson WG, Huang GD: Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. In press
Cited by
Items 701–800 of 879
Brackney, D. E. (2010) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 3
Niebauer, J., & Steidle‐Kloc, E. (2011) · Der Diabetologe · doi:10.1007/s11428-010-0617-4 · Cited by 1
Pastromas, S. C., Koulouris, S. N., & Manolis, A. S. (2010) · Hospital chronicles/Hospital Chronicles · doi:10.2015/hc.v5i4.215 · Cited by 1
Williams, M. E., & Stanton, R. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00031-x · Cited by 1
Joy, S. V., Freeman, J. S., & LaSalle, J. R. (2011) · Osteopathic Family Physician · doi:10.1016/j.osfp.2011.07.002 · Cited by 1
Kemp, T. (2010) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Common Clinical Conditions in Long-Term Care
Pandya, N. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-142-4_5 · Cited by 1
GASTROINTESTINAL SURGERY FOR NON-OBESE DIABETICS TYPE 2
COHEN, R. V. (2009) · Revista Médica Clínica Las Condes · Cited by 1
[FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE: THE EXEMPLE OF TYPE 2 DIABETES].
Paquot, N. (2015) · PubMed · Cited by 3
Chandalia, H. B., & Thadani, P. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0467-8 · Cited by 1
New Guidelines for Elderly Diabetic Patients
Lee, J. (2015) · Journal of Korean Diabetes · doi:10.4093/jkd.2015.16.2.89 · Cited by 1
Diabetes Under Control: Improving Hospital Care for Patients with Diabetes
Olohan, K. (2010) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000377698.25469.64 · Cited by 1
Stroke Update: Risk Factors and Primary Prevention of Stroke
Kim, J. G., & Lee, S. J. (2012) · Korean Journal of Stroke · doi:10.5853/kjs.2012.14.1.12 · Cited by 1
Type 1 Diabetes Mellitus in the Inclusive School Setting: Daily and Long Term Effects on Education
Hoffman, J. C., & Osipoff, J. N. (2015) · Advances in early childhood and K-12 education · doi:10.4018/978-1-4666-9452-1.ch003 · Cited by 2
Type 2 diabetes in primary care
Price, H. C. (2017) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738017713790 · Cited by 1
Sarras, M. P., & Leontovich, A. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_71 · Cited by 1
Research Questions in Data Science
Rose, S., & van der Laan, M. J. (2018) · Springer series in statistics · doi:10.1007/978-3-319-65304-4_1 · Cited by 2
Data-Adaptive Estimation in Cluster Randomized Trials
Balzer, L. B., van der Laan, M. J., & Petersen, M. L. (2018) · Springer series in statistics · doi:10.1007/978-3-319-65304-4_13 · Cited by 1
Comparative Effectiveness of Adaptive Treatment Strategies
Neugebauer, R. S., Schmittdiel, J. A., O’Connor, P. J., & van der Laan, M. J. (2018) · Springer series in statistics · doi:10.1007/978-3-319-65304-4_16 · Cited by 1
Atherosclerosis and Diabetic Nephropathy
Duivenvoorden, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_22 · Cited by 3
Complications and Management of Chronic Kidney Disease
Tuttle, K. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00011-x · Cited by 1
Kondratieva, D. S., Afanasiev, S. A., Будникова, О. В., Ворожцова, И. Н., Джаманович, А. Ш., & Shipulin, V. V. (2020) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2020-35-1-133-141 · Cited by 1
Foote, J. E., Giuseffi, J., & Munshi, M. N. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0117-5 · Cited by 1
Li, P.-I., & Guo, H. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.1091 · Cited by 1
el-Andari, R., Fialka, N., Kang, J. J. H., Bozso, S., Nagendran, J., & Nagendran, J. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00618-0 · Cited by 1
Sivasankari, V., & Manivannan, E. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00957 · Cited by 2
Diabetes and the Brain – An Epidemiologic Perspective
Launer, L. J. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_5 · Cited by 2
Disfunción diastólica subclínica del ventrículo izquierdo en adolescentes con diabetes tipo 1
Herrera, R., Peralta-Cortázar, C., Contreras-Rodríguez, A., Hernández‐Rodríguez, J., & Manjarrez‐Gutiérrez, G. (2014) · Boletín Médico del Hospital Infantil de México · Cited by 4
The Diabetic Hospice Patient: Incorporating Evidence and Medications Into Goals of Care
Scheufler, J., & Prince‐Paul, M. (2011) · Journal of Hospice and Palliative Nursing · doi:10.1097/njh.0b013e3182330edc · Cited by 3
Syatriani, S., Ridwan, A., Djaffar, N., & Ansariadi, A. (2017) · International Journal of Sciences: Basic and Applied Research · Cited by 1
Endothelial Dysfunction in Diabetes
Chandel, S., Tiwari, R. K., & Dixit, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_5 · Cited by 2
CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
Vinnarasan, M., Ramasamy, S., Vinothiney, K., & Balaji, G. (2017) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2017/1262 · Cited by 1
Shah, L., & Burgner, A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47871-7.00040-x · Cited by 1
Moderne Antidiabetika in der Kardiologie
Schneider, C., & Pfister, R. (2018) · Aktuelle Kardiologie · doi:10.1055/a-0655-7407 · Cited by 1
Overview of Types of Disease, Their Epidemiology, and Treatments
Yasin, S., Chan, C. K. Y., & Brodar, K. E. (2018) · Springer eBooks · doi:10.1007/978-0-387-93826-4_2 · Cited by 1
Development of physiological metabolic models in diabetes based on data mining techniques
Georga, E. I. (2019) · University of Ioannina · doi:10.26268/heal.uoi.1420 · Cited by 1
Kondratieva, D. S., Afanasiev, S. A., Будникова, О. В., Ворожцова, И. Н., Akhmedov, S. D., & Kozlov, B. N. (2021) · Diabetes Mellitus · doi:10.14341/dm12484 · Cited by 1
Precision Medicine Approaches for Management of Type 2 Diabetes
Chen, D., Fulcher, J., SCOTT, E. S., & Jenkins, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_1 · Cited by 3
Atherogenesis, coronary heart disease and insulin resistance syndrome in diabetes
Zafrir, B., & Plutzky, J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch70 · Cited by 3
Type 2 Diabetes: General Introduction
Levy, D. (2011) · Wiley eBooks · doi:10.1002/9781444391152.ch5 · Cited by 1
Cardiovascular Disease in Diabetic Nephropathy: Pathophysiology and Treatment
Busch, M. (2012) · doi:10.1002/9781118494073.ch7 · Cited by 1
Linagliptin for elderly patients with type 2 diabetes – Authors' reply
Barnett, A. H., von Eynatten, M., Patel, S. D., & Woerle, H. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60104-5 · Cited by 1
Glycaemic control and cardiovascular outcome trials in type 2 diabetes
Bailey, C. J., Day, C., Campbell, I. W., & Schindler, C. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412458958 · Cited by 1
Bower, J. K. (2010) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 3
DIABETES CONTROL – THE LEGACY OF A MEMORY
Vijay, A. P., & Chan, S. (2009) · Journal of Health and Translational Medicine · doi:10.22452/jummec.vol12no2.2 · Cited by 1
4. Recent Topics in the Japan Diabetes Outcome Intervention Trial
Izumi, K., Kato, M., & Noda, M. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.824 · Cited by 1
Methods in Clinical Pharmacology
Rusch, L. M., & Dehn, C. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-56637-5_28-1 · Cited by 1
McCarthy, M. M., & Chyun, D. A. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch10 · Cited by 1
Diabetic Considerations in Cerebrovascular Disease
Chung, C. J., Ellozy, S. H., Marin, M. L., & Faries, P. L. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_13
Diabetes Mellitus Prevention and Treatment
Dunn, A. V., & Nyalakonda, K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-380-0_5
The Effect of Practice Facilitation on Diabetes Outcome Measures
Longley, M. J. (2012) · SOPHIA (St. Catherine University)
REGULATION OF ATP BINDING CASSETTE TRAN SPORTER A1 AND G1 EXPRESSION BY
Ku, C. S. (2010) · Lincoln (University of Nebraska)
Peripheral vascular and cerebrovascular disease in diabetes mellitus
Mukherjee, D. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch75 · Cited by 2
Nutritional modulation of hepatic lipid metabolism in health and disease
Johnston, R. D. (2012) · Nottingham ePrints (University of Nottingham)
Glycemia and CVD and Its Management
Stephens, J. W., Mallipedhi, A., & Bain, S. C. (2014) · Wiley eBooks · doi:10.1002/9781118337967.ch5
Update Typ-2-Diabetes anhand ausgewählter aktueller Publikationen
Kellerer, M. (2009) · Der Diabetologe · doi:10.1007/s11428-008-0368-7
TRANSLATIONAL MEDICINE AND ITS IMPACT ON DIABETES DRUG DEVELOPMENT
Calle, R. A., & Taylor, A. E. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976087.004
Bilous, F. R., & Donnelly, R. (2010) · Wiley eBooks · doi:10.1002/9781444391374.ch14
Interventional Management of Diabetic Coronaropathy and Diffuse Coronary Artery Disease
Yu, J., Castellano, J. M., Mehran, R., & Fuster, V. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_77
Physical activity and diabetic complications in patients with type 1 diabetes
Wadén, J. (2010) · Helda - University of Helsinki Institutional Repository · Cited by 2
Venskutonytė, L. (2013) · Figshare
Systemic and Ocular Factors Influencing Diabetic Retinopathy
Browning, D. J. (2010) · Springer eBooks · doi:10.1007/978-0-387-85900-2_4
Lifestyle intervention strategies for type 2 diabetes management.
Wycherley, T. P. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
The Role of DNA Methylation in Type 1 and 2 Diabetes as Related to Endothelial Cell Dysfunction
Sarras, M. P. (2015) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2015.01.00005
Respuesta de la Dra. Lourdes del Santo Mora
Mora, L. D. S. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)64010-0
Respuesta de la Dra. M.a Dolores Prieto Rivas
Rivas, M. A. P. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)66011-5
Lower, faster, better: the delusions of surrogate markers in hypertension
Wierzbicki, A. S., & Ferro, A. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12185
Pavlova, M. G., & Zilov, A. V. (2011) · Problems of Endocrinology · doi:10.14341/probl201157348-52 · Cited by 1
Management of Diabetes Mellitus in Patients with Acquired Immunodeficiency Syndrome
Miulescu, R. D., Neamțu, M. C., Dănoiu, S., Culman, M., Păun, D. L., & Poiană, C. (2014) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2014-0018
Respuesta del Dr. Manuel Delgado Gómez
Gómez, M. D. (2010) · Avances en Diabetología · doi:10.1016/s1134-3230(10)66012-7
Factores de riesgo de complicaciones vasculares en extremidades inferiores en pacientes diabéticos
Monréal, M. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2010.10.011 · Cited by 2
Shaw, K. (2009) · Practical Diabetes · doi:10.1002/pdi.1365
Renda, A. M. G. F., & Spadea, G. C. F. (2013) · Journal of Gerontology & Geriatric Research · doi:10.4172/2167-7182.1000128
Hiperuricemia y alteración del metabolismo de la glucosa: implicaciones de una relación compleja
Boronat, M. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.11.005
Triches, C. B., Gross, J. L., & de Azevedo, M. J. (2009)
Gideon, V., & Brodie, E. C. (2014) · The Knowledge Bank (The Ohio State University)
Insulin therapy in type 2 diabetes patients : balancing between evidence and experience
van Avendonk, M. J. P. (2010) · Utrecht University Repository (Utrecht University)
Liao, E. P., & Poretsky, L. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.006
El examen físico en las consultas integrales de diabetes mellitus
Arias, O. D. R., Almaguer, F. R., Villalón, M. C. M., & Reyes, K. L. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Chyun, D. A. (2010) · Evidence-Based Nursing · doi:10.1136/ebn.13.1.3
Effects of glucose-lowering drugs in patients with diabetes and myocardial infarction
Mellbin, L., Malmberg, K., & Rydén, L. (2011) · Diabetes Management · doi:10.2217/dmt.11.8
Prise en charge des syndromes coronariens aigus
Tardif, J., L'Allier, P. L., & FITCHETT, D. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.017
New Position Papers on Type 2 Diabetes Management
Brett, A. S. (2009) · Journal watch · doi:10.1056/jw200902030000001
Ideal basal insulin: opportunities from designer proteins.
Shah, S. N., & Das, A. K. (2014) · PubMed
The Epidemiology of Coronary Artery Disease in Older Adults
Newman, A. B. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_23
Review Article Diabetes in the Elderly: Critical Appraisal in Management
Baruah, M. P., Kalra, S., Mathew, J., Unnikrishnan, A., Bantwal, G., & Rakesh, S. (2010)
Meschia, J. F., Moore, W. S., Pearson, T. A., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., et al. (2010)
Originales, T., Buchaca, E. F., Faxas, I., Rodríguez, L. B., Rojas, S. B., García, D. H., Díaz, I. M., Rodríguez, L., & Valdés, F. F. (2010) · Revista Cubana de Medicina
Diabetes Mellitus and Cardiovascular Risk : epidemiology, etiology and intervention
Rautio, A. (2016) · DiVA (Digitala Vetenskapliga Arkivet)
Management of the older person with diabetes mellitus
Oba, K. (2012) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.49.561
Noda, M., Kato, M., & Izumi, K. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.2231
Diabetic Nephropathy: Taking the Lead
Bansal, V. (2012) · Nephrology times · doi:10.1097/01.nep.0000421591.35327.88
Guest Editorial Diabetes in the elderly: Need for Focused Care
Baruah, M. P. (2010)
Leung, J. Y. T. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166166
Dedov, I. I., Galstyan, G. R., Grigoryan, O. R., Esayan, E. R. M., Калашников, В. Ю., Кураева, Т. Л., Mayorov, A. Y., Peterkova, V. A., & Smirnova, O. M. (2015) · CyberLeninK (CyberLeninka)
Peters, K. R. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.12.35s
Metadata
- Authors
- Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., & Sherwin, R. S.
- Affiliations
- University of Miami (US)
- Park Nicollet Clinic (US)
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of California, San Francisco (US)
- University of Bristol (GB)
- American Diabetes Association (US)
- Saint Luke's Hospital (US)
- Carl T. Hayden Veterans Affairs Medical Center (US)
- Yale University (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-01-01
- Volume
- 32
- Issue
- 1
- Pages
- 187-192
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2606812
- OpenAlex
- W2181092548
- Cited by
- 881
- References
- 22
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 13 · 2023: 24 · 2022: 23 · 2021: 32 · 2020: 37 · 2019: 40 · 2018: 43 · 2017: 46 · 2016: 53 · 2015: 70 · 2014: 56 · 2013: 68 · 2012: 101
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Amylin Pharmaceuticals
- Sanofi
- Edwards Lifesciences
- Osiris Therapeutics
- Insulet Corporation
- MannKind Corporation
- Halozyme
- Dexcom
- Tandem Diabetes Care
- Daiichi-Sankyo
- Novo Nordisk
- Pfizer Pharmaceuticals
- Daiichi Sankyo Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- tight glycemic control, cardiovascular events, type 1 diabetes, type 2 diabetes, microvascular complications, HbA1c targets, ACCORD trial, ADVANCE trial, Diabetes Control and Complications Trial, UKPDS, diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, cardiovascular risk
- MeSH terms
- Adult, Aged, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Homeostasis, Humans, Hyperglycemia, Middle Aged, Risk Factors, Sensitivity and Specificity, Randomized Controlled Trials as Topic, Risk Assessment, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.